Q2 2023 Holdings
Filed 2023-08-11 | 7 holdings | $203.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pharvaris N.V.(PHVS) | COM | N69605108 | $56.7M | 3,743,450 | 27.9% |
| Lyell Immunopharma, Inc. | COM | 55083R104 | $30.8M | 9,700,000 | 15.2% |
| Kinnate Biopharma Inc. | COM | 49705R105 | $29.3M | 9,671,643 | 14.4% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $29.1M | 2,808,034 | 14.3% |
| Kura Oncology, Inc.(KURA) | COM | 50127T109 | $19.6M | 1,849,947 | 9.6% |
| Cymabay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $19.6M | 1,787,094 | 9.6% |
| Syndax Pharmaceuticals, Inc.(SNDX) | COM | 87164F105 | $18.3M | 875,000 | 9.0% |